Medicine composition for treating esophagitis

Abstract

The invention discloses a medicine composition for treating esophagitis. The medicine composition for treating the esophagitis is prepared from, by mass, 12-15 parts of anisodamine, 0.5-0.8 part of tamoxifen and 54-59 parts of allicin; dosage of administration for an adult is 1.2 mg of active ingredient/kg/day. The medicine composition for treating the esophagitis has the functions of clearing heat, diminishing inflammation, softening hardness to dissipate stagnation, relieving cough and asthma and regulating qi to alleviate pain, and has a remarkable curative effect in treating esophagitis-caused symptoms such as nausea and vomiting, dyspepsia, stomach bloating and hyperacidity. According to clinical experimental verifications, the medicine composition for treating the esophagitis is short in course of treatment, quick in result and free of toxic and side effects, and is worth being applied and popularized.

Description

technical field [0001] The invention relates to the field of western medicine, in particular to a pharmaceutical composition for treating esophagitis. Background technique [0002] Esophagitis generally refers to the inflammation caused by edema and congestion of the esophageal mucosa due to irritation or damage to the superficial or deep layers of the esophageal mucosa. Chemical stimuli include gastric acid, bile, spirits, strong acids, strong alkalis, drugs, etc.; physical stimuli include hot food, drinks, foreign bodies in the esophagus, long-term placement of nasogastric tubes, etc. Esophagitis can also be caused by local damage to the esophagus caused by chemotherapy or radiotherapy, or by mycobacterium tuberculosis, fungal or viral infection caused by the patient's own resistance decline. The most common clinical manifestation is reflux esophagitis caused by acid reflux. [0003] The hazards of esophagitis are manifested in the following aspects: On the one hand, eso...

AI Technical Summary

Problems solved by technology

[0003] The hazards of esophagitis are manifested in the following aspects: On the one hand, esophagitis may cause gastric bleeding. Generally, some patients have hematemesis, some have blood in the stool, and some patients also have iron deficiency anemia. On the other hand, esophagitis may also cause ulcers, which will cause great difficulty for patients to swallow food, and may even penetrate the arteries, causing massive bleeding and life-threatening

If esophagitis is allowed to develop without timely treatment measures, it is likely to cause esophagus stricture, spread to other organs and cause other organ lesions, leading to more serious consequences

[0004] At present, there are many ways to treat esophagitis. Although some problems can be solved, some patients may cause trauma to the interpharyngeal mucosa after treatment, forming scars, resulting in adverse consequences, making the posterior pharyngeal wall atresia, adhesion, and more uncomfortable.